International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Compounding Challenges for Immunocompromised Patients

Author(s): McElhiney Linda F

Issue: Nov/Dec 2008 - Arthritis and Immunological Diseases
View All Articles in Issue

Page(s): 482-487

Compounding Challenges for Immunocompromised Patients Page 1

Compounding Challenges for Immunocompromised Patients Page 2

Compounding Challenges for Immunocompromised Patients Page 3

Compounding Challenges for Immunocompromised Patients Page 4

Compounding Challenges for Immunocompromised Patients Page 5

Compounding Challenges for Immunocompromised Patients Page 6

Download in electronic PDF format for $75

Abstract: Compounding pharmacists play a vital role in the prevention, duration, and conclusion of diseases and infections for immunocompromised patients. Caused by deficiencies such as the human immunodeficiency virus, acquired immunodeficiency virus and cancers, which warrant immunosuppression during chemotherapy, immunodeficiency renders the patient vulnerable to viruses, infections, and diseases that, in the immunocompromised state, could develop lethally. By working closely with patients, compounding pharmacists are able to provide correct dosages, strengths, and drug combinations for each individual situation.

Related Keywords: immune deficiency, HIV, immunocompromised, immunosuppression, human immunodeficiency virus, AIDS, cancer chemotherapy, organ transplantation, bone marrow transplant, stem cell transplant, opportunistic infections, antifungal agents, antibiotics, antimicrobial agents, formulations

Related Categories: CANCER AND AIDS, FORMULATIONS, ALLERGY/IMMUNOLOGY/INFLAMMATION, DOSAGE FORMS/DRUG CARRIERS, INFECTIOUS DISEASE, PREVENTIVE MEDICINE/WELLNESS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Compounding Challenges for Immunocompromised Patients McElhiney Linda F	Nov/Dec 2008 Pg. 482-487
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2 Horace Alexis E, Akbarian-Tefagh Jessica	Nov/Dec 2013 Pg. 446-450
Human Immunodeficiency Virus and the Acquired Immune Deficiency Syndrome Mathews Elizabeth	Sep/Oct 2000 Pg. 334
Basics of Compounding for the Treatment of Warts Allen Loyd V Jr	Mar/Apr 2004 Pg. 126-129
Mycophenolate Mofetil 50-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2006 Pg. 141
Compounding with Biotechnology Products, Part 2: Product-specific Considerations Allen Loyd V Jr	Nov/Dec 2022 Pg. 446-466
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1 Horace Alexis E, Akbarian-Tefagh Jessica	Sep/Oct 2013 Pg. 388-391
Providing Positive Outcomes through Compounding for Animal Cancer Patients Davidson Gigi S	Jul/Aug 2000 Pg. 264-272
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient McElhiney Linda F	Mar/Apr 2010 Pg. 112-115
Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report Mixon Bill, Mixon Jan, Isbey Edward K III, Sprinkle Shari	Sep/Oct 2014 Pg. 370-377
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1 Cutter Christopher B	Jan/Feb 2004 Pg. 16-21
Calculations: Compounding for Cancer Patients Stockton Shelly J	Jan/Feb 2008 Pg. 62
Oral Mucositis: Etiology and Clinical and Pharmaceutical Management Zur Eyal	Jan/Feb 2012 Pg. 22-33
Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 45
Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension Allen Loyd V Jr	May/Jun 2021 Pg. 234
Antiemetic Injection for Cancer Chemotherapy Allen Loyd V Jr	May/Jun 1997 Pg. 175
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 2 Cutter Christopher B	Mar/Apr 2004 Pg. 96-99
Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient Bramwell Bethany	Jul/Aug 2011 Pg. 316-319
PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial Williams LaVonn A	May/Jun 2013 Pg. 262-263
Return to Top